Sexually transmitted infections

 
Bacterial Vaginosis Recurrence Drops with Partner Treatment: Daily Dose
April 28, 2025

Your daily dose of the clinical news you may have missed.

Oral Gepotidacin Noninferior to Standard Therapy for Gonorrhea in Phase 3 Trial
April 15, 2025

Data from the EAGLE-1 study found gepotidacin to be noninferior to ceftriaxone plus azithromycin for treating uncomplicated urogenital gonorrhea.

Universal Syphilis Screening in the ED Outperforms Targeted Approaches: Daily Dose
April 04, 2025

Your daily dose of the clinical news you may have missed.

FDA Authorizes Marketing of First At-Home Test for Chlamydia, Gonorrhea, Trichomoniasis
March 31, 2025

The Women’s Sexual Health Test (Visby Medical) delivers results in approximately 30 minutes using a vaginal swab.

New Study Suggests Bacterial Vaginosis May be Sexually Transmitted
March 28, 2025

New research shows that treating both men and women with topical and oral antibiotics lowers the odds of bacterial vaginosis recurrence by more than half.

Sanofi's Chlamydia Vaccine Granted FDA Fast Track Designation
March 26, 2025

The FDA granted fast track designation to Sanofi’s chlamydia vaccine candidate today, aiming to prevent infections and address an unmet public health need.

Universal ED Syphilis Screening Outperforms Targeted Approaches, Study Shows
March 20, 2025

CROI 2025: Researchers reported that a universal syphilis screening program identified more cases than programs targeting specific patient populations.

FDA Clears Cobas Liat Assay Panels for Point-of-Care Diagnosis of Sexually Transmitted Infections
January 23, 2025

These test panels allow clinicians to diagnose multiple STIs from a single specimen, with results available in about 20 minutes.

CDC Releases Annual STI Report: Daily Dose
November 27, 2024

Your daily dose of the clinical news you may have missed.

USPSTF Reaffirms Syphilis Screening for Pregnant Individuals Amid Rising Congenital Syphilis Rates
November 26, 2024

Comments on the draft recommendation can be submitted through December 23, 2024.